Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study

PURPOSE: Dydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinological characteristics, oocyte retrieval and pregnancy outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jialyu, Xie, Qin, Lin, Jiaying, Lu, Xuefeng, Zhu, Jing, Gao, Hongyuan, Cai, Renfei, Kuang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997218/
https://www.ncbi.nlm.nih.gov/pubmed/32099323
http://dx.doi.org/10.2147/DDDT.S230129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997218/
https://www.ncbi.nlm.nih.gov/pubmed/32099323
http://dx.doi.org/10.2147/DDDT.S230129

Ejemplares similares